Precure, LLC will combine protein, genetic and long-term clinical data from the same people to find disease signals years before…
A virtual-cell model trained on 38 million protein measurements matched real treatment outcomes in women with triple-negative breast cancer.
Flagship's ProFound Therapeutics gets up to $35M from the Gates Foundation to hunt new preeclampsia drug targets.